Loading…
Tiziana Life Sciences Ltd is projected to rise to $1.57 by 2027, a +7% move from its current price of $1.47. TLSA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.41 | $1.47 | $1.53 | +0.01% |
| May 30 | $1.38 | $1.47 | $1.56 | +0.03% |
| May 31 | $1.36 | $1.47 | $1.58 | +0.04% |
| Jun 1 | $1.35 | $1.47 | $1.60 | +0.05% |
| Jun 2 | $1.34 | $1.47 | $1.62 | +0.07% |
| Jun 3 | $1.32 | $1.47 | $1.63 | +0.08% |
| Jun 4 | $1.31 | $1.47 | $1.65 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.31 | $1.47 | $1.65 | +0.09% |
| Week 2 | $1.25 | $1.47 | $1.73 | +0.18% |
| Week 3 | $1.21 | $1.47 | $1.80 | +0.28% |
| Week 4 | $1.17 | $1.48 | $1.85 | +0.37% |
| Week 5 | $1.14 | $1.48 | $1.91 | +0.46% |
| Week 6 | $1.12 | $1.48 | $1.95 | +0.55% |
| Week 7 | $1.09 | $1.48 | $2.00 | +0.65% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tiziana Life Sciences Ltd is a biotechnology company that engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. Its lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications.
Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.
TLSA is a biotechnology company with a current price of $1.48 and a market capitalization of $188.34M. Its stock is ranked 3875 by market cap. The current price and market cap place TLSA among smaller-cap biotechnology names with active exploration of immunology and inflammatory disease therapies.
A major floor 29.9% below — a decisive break under it would weaken the trend.
The nearest floor, 17.7% below — buyers have tended to step in here.
The nearest ceiling, 9.5% above — a clean break opens room to run.
A major ceiling 24.5% above — clearing it would confirm fresh momentum.
Key TLSA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TLSA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.51 | Sell | $1.48 | Sell |
| MA 10 | $1.46 | Buy | $1.47 | Buy |
| MA 20 | $1.45 | Buy | $1.44 | Buy |
| MA 50 | $1.33 | Buy | $1.39 | Buy |
| MA 100 | $1.39 | Buy | $1.42 | Buy |
| MA 200 | $1.61 | Sell | $1.47 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.60 | Neutral |
| Stoch RSI (14) | 24.42 | Neutral |
| CCI (20) | 20.29 | Neutral |
| Williams %R (14) | -53.85 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -6.96 | Sell |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 46.15 | Neutral |
| TRIX (15) | 0.52 | Buy |
| Awesome (5,34) | 0.14 | Buy |
| Ultimate (7,14,28) | 56.16 | Neutral |
| Momentum (10) | -0.09 | Sell |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 1.51 | Sell |
| ADX (14) | 14.51 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is bullish. RSI14 sits at 50, with the short-term moving average (SMA50) at $1.33 and the longer-term SMA200 at $1.62, signaling modest positive momentum. The stock shows a defined support at $1.15 and a resistance at $1.61, framing a 30-day price range from $1.10 to $1.99.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.15 | $1.47 | $2.12 | 0% | Neutral | |
| $1.18 | $1.57 | $2.26 | +7% | Neutral | |
| $1.34 | $1.88 | $2.84 | +28% | Bullish | |
| $1.37 | $2.00 | $3.15 | +36% | Bullish | |
| $1.64 | $2.47 | $4.03 | +68% | Bullish | |
| $2.25 | $3.50 | $5.88 | +138% | Bullish | |
| $2.21 | $3.54 | $6.10 | +141% | Bullish | |
| $2.12 | $3.50 | $6.17 | +138% | Bullish | |
| $2.29 | $3.89 | $7.01 | +165% | Bullish | |
| $2.18 | $3.81 | $7.02 | +160% | Bullish | |
| $3.47 | $6.90 | $13.79 | +370% | Bullish | |
| $5.64 | $12.53 | $28.17 | +753% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.15 | $1.47 | $1.73 | +0.00% |
| June 2026 | $1.21 | $1.43 | $1.76 | -2.51% |
| July 2026 | $1.23 | $1.49 | $1.86 | +3.81% |
| August 2026 | $1.25 | $1.52 | $1.93 | +2.15% |
| September 2026 | $1.19 | $1.46 | $1.89 | -3.70% |
| October 2026 | $1.19 | $1.47 | $1.91 | +0.36% |
| November 2026 | $1.25 | $1.56 | $2.06 | +6.38% |
| December 2026 | $1.27 | $1.59 | $2.12 | +1.82% |
Click any year to see its month-by-month TLSA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TLSA to range from $1.15 to $2.12 through 2026. The $1.47 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The TLSA price prediction for 2027 points to an average of $1.57 (low $1.18, high $2.26) — a potential gain of +7% on today's $1.47. Price action looks broadly range-bound.
In 2028, TLSA is projected to trade between $1.34 and $2.84, averaging $1.88 — a potential gain of +28% from today's $1.47. That is up +19% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Tiziana Life Sciences Ltd's 2029 outlook centres on $2.00, within a $1.37 to $3.15 range. That is up +6% on the projected 2028 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2030, TLSA could reach as high as $4.03, with a base case around $2.47 and support toward $1.64 — roughly +68% from $1.47. Buyers look set to stay in control over this stretch.
Expect TLSA to range from $2.25 to $5.88 through 2031. The $3.50 average target implies a +138% move from current prices. That is up +42% on the projected 2030 average. Momentum favours further upside here.
The TLSA price prediction for 2032 points to an average of $3.54 (low $2.21, high $6.10) — a potential gain of +141% on today's $1.47. Buyers look set to stay in control over this stretch.
In 2033, TLSA is projected to trade between $2.12 and $6.17, averaging $3.50 — a potential gain of +138% from today's $1.47. That is -1% versus the projected 2032 average. Momentum favours further upside here.
Tiziana Life Sciences Ltd's 2034 outlook centres on $3.89, within a $2.29 to $7.01 range. That is up +11% on the projected 2033 average. That marks a +165% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, TLSA could reach as high as $7.02, with a base case around $3.81 and support toward $2.18 — roughly +160% from $1.47. Momentum favours further upside here.
Expect TLSA to range from $3.47 to $13.79 through 2040. The $6.90 average target implies a +370% move from current prices. That is up +81% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The TLSA price prediction for 2050 points to an average of $12.53 (low $5.64, high $28.17) — a potential gain of +753% on today's $1.47. Momentum favours further upside here.
Investing $1,000 in TLSA today (≈ 680.272109 TLSA) could be worth
$8,525.69
+$7,525.69 (+753%) by 2050 · US Dollar
Based on the average projected TLSA price of $12.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TLSAwould be worth at today's price.
$1,000 invested in TLSA on May 27, 2025 (≈ 699.300725 TLSA) would be worth
$1,027.97
+$27.97 (+2.8%) today · 1.03× · US Dollar
Based on a TLSA entry price of $1.43 vs. today's $1.47.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.61 | $913.04 | -8.7% |
| 1 month ago | $1.26 | $1,166.67 | +16.7% |
| 3 months ago | $1.46 | $1,006.85 | +0.7% |
| 6 months ago | $1.8 | $816.67 | -18.3% |
| 1 year ago | $1.43 | $1,027.97 | +2.8% |
| All time (5.0y) ago | $2.39 | $615.06 | -38.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TLSA forecast.
Our base-case forecast reaches $2.90 around 2031.
Implied market cap at $2.90: $369.05M
The multi-year forecast is bullish into the back half of the decade, with higher averages and sizable upside projected. For 2030 the model shows an average price of $2.72 with a min of $1.78 and a max of $4.50, delivering an ROI of 83.9% and a bullish sentiment. By 2040 the average is projected to $8.02 with a min of $3.89 and a max of $16.36, delivering an ROI of 441.6% and a bullish sentiment.
In 2050 the average is $14.95 with a min of $6.73 and a max of $34.38, delivering an ROI of 910% and a bullish sentiment. These figures illustrate meaningful upside across the long horizon, though they are estimates and not guarantees.
Tap a question to reveal the answer.
Min $1.78, Avg $2.72, Max $4.50; ROI 83.9%; Sentiment BULLISH.
The forecast shows bullish sentiment from 2028 onward with rising averages to $2.72 by 2030 and up to $14.95 by 2050, and ROIs of 83.9% in 2030, 441.6% in 2040, and 910% in 2050. 2026 is neutral with Min $1.15, Avg $1.48, Max $2.16 and ROI 0%.
Yes. The 2040 forecast shows a max of $16.36, with an average of $8.02 and a min of $3.89; ROI 441.6% and sentiment BULLISH.
Current price is $1.48 and market cap is $188.34M.
RSI14 is 50; SMA50 is $1.33; SMA200 is $1.62; support at $1.15; resistance at $1.61; 30-day range is $1.10 to $1.99; annualized volatility is 90%.
Tiziana Life Sciences Ltd Community Discussion
0Share your Tiziana Life Sciences Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.